Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives

Published: March 28, 2024

Tandon figure
  • Wearable biosensors, or "wearables," are crucial in congenital heart disease, spanning both consumer/wellness and medical-grade devices. These devices, encompassing photoplethysmography (PPG), electrocardiogram (EKG), and accelerometry sensors, enable continuous, extended monitoring of vital health metrics such as arrhythmias, oxygen saturation, physical activity, and heart rate.
  • Through continuous physiological monitoring, wearables might detect early changes in patient status. This access to personal health data could empower patients and parents, enabling them to proactively manage their well-being in the face of congenital heart disease.
  • This science advisory investigates the current use of wearables in congenital heart disease (CHD) and explores ways to improve these technologies for clinicians and patients alike. Additionally, it addresses ethical and regulatory concerns surrounding the application of wearables, highlighting the need to overcome these challenges to maximize their effectiveness within this demographic.